Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: cancer therapeutics - Molecular Templates

Next Previous
Drug Profile

Research programme: cancer therapeutics - Molecular Templates

Alternative Names: 3F7; 5G2; MT 2289; MT 4019; MT 6868; MT-2274; MT-6020; MT-SAM3

Latest Information Update: 07 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Molecular Templates
  • Class Antineoplastics; Bacterial toxins; Drug conjugates; Recombinant proteins; Small interfering RNA
  • Mechanism of Action CD38 antigen inhibitors; Programmed cell death-1 ligand-1 inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hodgkin's disease; Malignant melanoma; Multiple myeloma; Solid tumours

Most Recent Events

  • 07 May 2025 Discontinued - Preclinical for Malignant melanoma in USA (Parenteral)
  • 07 May 2025 Discontinued - Preclinical for Multiple myeloma in USA (Parenteral)
  • 07 May 2025 Discontinued - Preclinical for Solid tumours in USA (Parenteral)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top